PTPRC and cancer: FAP expressing immune cells have been seen previously (Arnold et al, 2014; Cremasco et al, 2018) and considered to comprise CD45+ cells, which is consistent with the increased proinflammatory cytokine release by cancer cells deprived of extracellular citrate.